The content on this page is intended for US healthcare professionals only. By clicking "Yes," you confirm that you are a licensed healthcare professional in the United States.
CorMedix Therapeutics is committed to researching and developing products that improve patient care and advance medicine. See below for a brief description of our ongoing and recently completed clinical trials. For more information, visit ClinicalTrials.gov.
| Study ID | NCT06822426 |
| Study Title | Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC) |
| Phase | Phase 3 |
| Status | Recruiting |
| ClinicalTrials.gov | NCT06822426 |
| Study ID | NCT06714864 |
| Study Title | Open-Label Study to Assess Safety and Time to Catheter-related Bloodstream Infections (CRBSI) in Subjects From Birth to < 18 Years of Age |
| Phase | Phase 4 |
| Status | Recruiting |
| ClinicalTrials.gov | NCT06714864 |
| Study ID | CD101.IV.3.08 |
| Study Title | Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (ReSPECT) |
| Phase | Phase 3 |
| Status | Completed |
| ClinicalTrials.gov | NCT04368559 |
CorMedix Therapeutics has licensed US commercial rights to rezafungin from Mundipharma, which is the sponsor of this study.
| Study ID | TMC-ORI-11-01 |
| Study Title | Open Label, Dose-finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Participants With Suspected or Confirmed Bacterial Infections |
| Phase | Phase 1 |
| Status | Completed |
| ClinicalTrials.gov | NCT02134301 |
| Study ID | ML-ORI-201 |
| Study Title | Study to Evaluate the Safety of Intravenous Oritavancin for the Treatment of Children With Skin Infections |
| Phase | Phase 2 |
| Status | Completed |
| ClinicalTrials.gov | NCT05599295 |
| Study ID | Rempex 507 |
| Study Title | Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections (TANGOKIDS) |
| Phase | Phase 1 |
| Status | Active, not recruiting |
| ClinicalTrials.gov | NCT02687906 |
| Study ID | ML-VAB-201-3248-2 |
| Study Title | A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With Complicated Urinary Tract Infection, Including Acute Pyelonephritis |
| Phase | Phase 2 |
| Status | Active, not recruiting |
| ClinicalTrials.gov | NCT06672978 |